Clinical Trial

Outcomes of a Novel Technique Minimal Scar Mastectomy

Recruiting
View on ClinicalTrials.gov →
Summary
Nipple sparing mastectomy is oncologically safe and has a good cosmetic outcome. However, nipple sparing mastectomy was conventionally performed with reconstruction. Minimal scar mastectomy (MSM) is a novel technique which could allow women, with non-ptotic breasts, who do not want reconstruction, to conserve their nipple areolar complex (NAC) and avoid the transverse scar associated with modified radical mastectomy. This is the first study on the oncologic and surgical outcomes of MSM.
Trial Details
NCT Number NCT06676761
Lead Sponsor KK Women's and Children's Hospital
Conditions Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment 100 participants
Start Date 2017-03-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-06